Shenyang Sunshine Pharmaceutical Co., LTD.

Related records

Trials (41)

• A Multi-site Bridging Study of Nalfurafine Hydrochloride Orally Disintegrating Tablet
• A Pharmacokinetics and Safety Study of Narfurine Hydrochloride Orally Disintegrating Tablets
• A Phase 1 Mass Balance Study of [¹⁴C]SSS17 in Healthy Chinese Males
• A Phase 1 Study of SSGJ-709 in Patients With Advanced Malignant Tumors
• A Phase 1 Study of SSS17 in Healthy Subjects.
• A Phase I Clinical Study of SSS59 Monotherapy in Patients With Advanced Malignant Tumors
• A Phase I Study of SPGL008 in Subjects With Advanced Malignant Tumors
• A Phase I Study of SSGJ-612 in Patients With Advanced Solid Tumors
• A Phase Ib Clinical Study for rhTPO in the Treatment of Thrombocytopenia in Patients With Chronic Liver Disease
• A Phase II Clinical Study Evaluating SSGJ-706 in Combination Therapy for Advanced Gastrointestinal Cancers
• A Phase II Study of SSGJ-612 Plus a HER2-Targeted ADC in HR-Positive, HER2-Low or HER2-Ultralow Expression Metastatic Breast Cancer
• A Phase II Study of SSGJ-706 Monotherapy and Combination Therapy in Advanced Non-Small Cell Lung Cancer（NSCLC） Patients
• A Randomized Trial Comparing Optimized rhTPO Treatment With Eltrombopag Treatment in Pre-treated ITP Pts
• A Study Evaluating the Food Effect on the Pharmacokinetics of SSS17 Capsules in Chinese Healthy Subjects
• A Study of SSS17 in Healthy Subjects
• A Study of SSS68 Following a Single Subcutaneous Administration in Healthy Adult Participants
• A Study to Assess the Safety and Tolerability of SSS11 in Healthy Subjects.
• A Study to Determine the Safety, Tolerability, PK and Preliminary PD of SSS11 in Chinese Healthy Adult Volunteers
• A Study to Evaluate the Safety, Tolerability, and Pharmacokinetics of SSS39 Injection in Healthy Chinese Subjects
• A Trial With Humanized TNFα Monoclonal Antibody Injection by Single Dose and Dose Escalation in Healthy Subjects